Research and Development

The Research and Development team at Cour Pharmaceuticals Development focuses on advancing nanoparticle technology to modulate the immune system for multiple sclerosis treatment. Comprising experts in immunology, formulations, and clinical operations, the team collaborates to design, develop, and test innovative therapeutic solutions while ensuring quality and compliance throughout the process. Their goal is to translate cutting-edge research into viable therapies that effectively address the needs of MS patients.